Author:
Franco Eduardo L,Duarte-Franco Eliane,Rohan Thomas E
Reference52 articles.
1. Schatzkin A. Intermediate markers in cancer research: theoretical and practical issues in the use of surrogate endpoints. In: Franco EL, Rohan TE, editors. Cancer precursors: epidemiology, detection, and prevention. New York: Springer; 2002. p. 46–59.
2. Kelloff GJ, Sigman C. Chemoprevention. In: Franco EL, Rohan TE, editors. Cancer precursors: epidemiology, detection, and prevention. New York: Springer; 2002. p. 374–88.
3. Screening for cancer PDQ® screening/detection—health professionals. http://cancer.gov/templates/list.aspx?viewid=33b41db3-9099-4705-a77d-590a60637451. Accessed 10 May 2002.
4. Kramer BS. NCI state-of-the-art statements on cancer screening. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer prevention and control. New York: Marcel Dekker; 1995. p. 721.
5. Mammography versus clinical examination of the breasts;Baines;J Natl Cancer Inst Monogr,1997
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献